CROs/Service Providers

PRA Health Sciences becomes latest big CRO to launch IPO

Thursday, November 13, 2014 03:38 PM

By Ronald Rosenberg
CenterWatch Staff Writer

PRA Health Sciences launched its initial public offering this morning, raising $306 million from the sale of nearly 17 million shares at $18 per share—below plans it announced in September to raise up to $375 million.

More... »


Coté Orphan launches CRO to simplify orphan drug developement process

Wednesday, November 12, 2014 03:22 PM

Coté Orphan, a regulatory affairs advisory firm based in Silver Spring, Md., has added a new line of service for its clients by providing CRO services that will help organizations navigate the clinical trials process through the lens of regulatory affairs. With the addition of the CRO services, Coté Orphan provides companies a complete and robust solution to those developing or seeking to develop orphan drugs.

More... »

Subscribe to The CenterWatch Monthly

INC Research launches its IPO

Monday, November 10, 2014 02:38 PM

By Ronald Rosenberg
CenterWatch Staff Writer

Global CRO INC Research launched its initial public offering today, raising $150 million by selling just over 8.1 million shares at $18.50 per share—the middle of the expected $17-$20 range. The stock climbed 9% in early trading past $20.75 before settling to $20 by late afternoon.

More... »

Medidata, PPD partner to offer new approach to risk-based monitoring

Monday, November 10, 2014 12:22 PM

Medidata, a New York-based global provider of cloud-based solutions for clinical research in life sciences, and Pharmaceutical Product Development (PPD), a Wilmington, N.C.-based global CRO, are expanding their partnership to provide the life science industry with a more comprehensive approach to risk-based monitoring (RBM)—aimed at conducting drug development more intelligently, more quickly and more cost-effectively.

More... »

Charles River, CHDI Foundation extend Huntington's disease collaboration

Monday, November 10, 2014 12:18 PM

CRO Charles River International, based in Wilmington, Mass., and the CHDI Foundation, a U.S., privately-funded, nonprofit, biomedical research organization, have extended an ongoing collaboration for an additional five years through 2019. The collaboration, which began in 2005, is focused on discovering novel drugs for Huntington's disease.

More... »

GVK BIO to acquire Vanta Bioscience

Friday, November 7, 2014 01:09 PM

GVK BIO, a Hyderabad, India-based discovery R&D organization, will acquire Vanta Bioscience, a full-service preclinical GLP toxicology and safety assessment CRO operating from Chennai, India.

More... »

FDA selects Icon to work on PRO measures for pneumonia trials

Thursday, November 6, 2014 12:38 PM

Global CRO Icon, based in Dublin, has been awarded a project by the FDA to develop an industry-standard Patient Reported Outcome (PRO) measure that can be used in anti-bacterial drug development trials for hospital-acquired bacterial pneumonia (HABP). 

More... »

ERT acquires eClinical Insights

Thursday, November 6, 2014 12:36 PM

ERT, a Philadelphia, Pa.-based global solution provider for high-quality patient safety and efficacy endpoint data collection, has acquired eClinical Insights (eCI), a Cambridge, Mass.-based provider of cloud-based clinical trials management software.

More... »

DaVita Clinical Research, St. Anthony Hospital collaborate

Wednesday, November 5, 2014 01:57 PM

DaVita Clinical Research (DCR), a Minneapolis, Minn.-based specialty CRO, now can offer its sponsors increased patient access, on-site ancillary services and specialty physician experience in key therapeutic areas through a partnership with St. Anthony Hospital in Lakewood, Colo. 

More... »

Chiltern launches rebranding

Monday, November 3, 2014 02:37 PM

U.K.-based Chiltern has rebranded as a completely integrated and unified CRO with services that are "Designed Around You.”

More... »


CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 22

DaVita combines its two research CRO units to create an end-to-end CRO focused on kidney, end-stage renal disease

New crop of clinical trial matching services use patient’s molecular, genomic data for better fit

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

December

Growing adoption of feasibility review committees
Early reports cite fewer amendments, improved cycle time

AMCs vying to better compete for industry trials
Working to conquer study start-up delays, IRB review process

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

November

Private equity driving dynamic CRO growth
Enables CROs to pursue long-term strategies, while giving the space credibility

Baby boomers poised to reshape clinical trials industry
Millions of tech-savvy consumers already track their health, expect new treatments as they age

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs